Eleos Health Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
195
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$60M
- Investors
-
20
Eleos Health General Information
Description
Developer of a health technology platform designed to gather insights into behavioral health. The company's platform utilizes artificial intelligence to run in the background of mental health sessions and voice capabilities to analyze various data parameters giving insights and information about the patient, enabling clinicians to give personalized care and provide the necessary support.
Contact Information
Website
www.eleos.healthCorporate Office
- 1 Broadway
- Cambridge, MA 02142
- United States
Corporate Office
- 1 Broadway
- Cambridge, MA 02142
- United States
Eleos Health Timeline
Eleos Health Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series C) | 22-Jan-2025 | $60M | Completed | Generating Revenue | ||
| 5. Early Stage VC (Series B) | 08-Nov-2023 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A) | 05-Apr-2022 | Completed | Generating Revenue | |||
| 3. Seed Round | 13-Sep-2021 | Completed | Generating Revenue | |||
| 2. Seed Round | 01-Feb-2020 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | 17-Dec-2019 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Eleos Health Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Eleos Health Patents
Eleos Health Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-7960364-B2 | Methods for modulating the efficacy of nucleic acid based therapies | Inactive | 01-May-2007 | ||
| US-20100144840-A1 | Methods for modulating the efficacy of nucleic acid based therapies | Active | 23-Mar-1998 |
Eleos Health Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Eleos Health Investors (20)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alicorn | Venture Capital | Minority | ||
| Centerstone | Corporation | Minority | ||
| Greenfield Partners | Venture Capital | Minority | ||
| Michael & Susan Dell Foundation | Impact Investing | Minority | ||
| Union Tech Ventures | Venture Capital | Minority |
Eleos Health FAQs
-
When was Eleos Health founded?
Eleos Health was founded in 2019.
-
Where is Eleos Health headquartered?
Eleos Health is headquartered in Cambridge, MA.
-
What is the size of Eleos Health?
Eleos Health has 195 total employees.
-
What industry is Eleos Health in?
Eleos Health’s primary industry is Enterprise Systems (Healthcare).
-
Is Eleos Health a private or public company?
Eleos Health is a Private company.
-
What is Eleos Health’s current revenue?
The current revenue for Eleos Health is .
-
How much funding has Eleos Health raised over time?
Eleos Health has raised $126M.
-
Who are Eleos Health’s investors?
Alicorn, Centerstone, Greenfield Partners, Michael & Susan Dell Foundation, and Union Tech Ventures are 5 of 20 investors who have invested in Eleos Health.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
